Irini C.
- Country
- Greece
- Department
- 2nd Department of Ophthalmology
Research Overview
- Randomized trial of RD03/2016 (levofloxacin/ketorolac) versus dexamethasone/levofloxacin eye drops for inflammation/infection after cataract surgery
- Evaluation of Ranibizumab Port Delivery System Refill Regimen in Neovascular Age-Related Macular Degeneration: A Phase IIIb, Multicenter, Single-Arm Study
- Efficacy and Safety Evaluation of Xelafaslatide (ONL1204) in Geographic Atrophy Secondary to Age-related Macular Degeneration: A Phase 2 Randomized Controlled Trial
Data & Insights
Has run more than one trial at 17 of 107 partner sites.
Specializations
Ophthalmology
Clinical work is centered in ophthalmology, with attention to disorders affecting the eye and visual function in a hospital-based setting.
- Retinal disease
- Macular pathology
- Visual impairment
Her research activity reflects interest in medical conditions that influence sight and ocular health, supporting the evaluation of therapeutic options in eye care.
Retinal and macular disorders
Her clinical trial involvement includes conditions involving the retina and macula, where preservation of central vision and structural retinal integrity are key therapeutic concerns.
- Age-related macular degeneration
- Diabetic retinopathy
- Retinal vascular disease
This area is closely tied to interventions aimed at preventing progression of vision-threatening ocular disease.
Diabetic eye disease
Her research landscape also includes diabetic retinopathy and related diabetic eye complications, with therapeutic interest in protecting retinal function in patients affected by diabetes mellitus.
- Microvascular retinal damage
- Macular edema
- Vision preservation
These topics align with clinical efforts to address sight loss associated with metabolic disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.